Preoperative cardiac risk management

Radosav Vidaković1, Don Poldermans, Aleksandar N Nesković

  • 1Department of Cardiology, Clinical Hospital Zemun, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Acta Chirurgica Iugoslavica
|September 2, 2011
PubMed

Insights

Millions undergo noncardiac surgery yearly. This review details assessing and managing major adverse cardiac events (MACE) risk in these patients, crucial for improving perioperative outcomes.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Perioperative Medicine

Background:

  • Noncardiac surgery is common globally, with approximately 3% of patients experiencing major adverse cardiac events (MACE).
  • Perioperative cardiac complications contribute significantly to morbidity and mortality, yet their precise incidence is challenging to determine.
  • Cardiac risk assessment is vital for optimizing patient management during noncardiac procedures.

Purpose of the Study:

  • To review clinical risk factors, laboratory measurements, and non-invasive cardiac testing for assessing perioperative cardiac risk.
  • To discuss strategies for managing patients undergoing noncardiac surgery based on their cardiac risk profile.
  • To highlight the importance of preoperative cardiac evaluation for high-risk individuals.

Main Methods:

  • Review of existing literature on perioperative cardiac risk assessment and management.
  • Discussion of established scoring systems for predicting cardiac complications.
  • Emphasis on non-invasive cardiac imaging modalities for preoperative evaluation.

Main Results:

  • Perioperative cardiac risk is influenced by patient-specific risk factors and surgical procedure type.
  • Scoring systems aid in accurately assessing and stratifying patient risk.
  • Preoperative non-invasive testing guides management decisions, including medication or revascularization.

Conclusions:

  • Accurate assessment of perioperative cardiac risk is essential for noncardiac surgery patients.
  • Risk stratification enables tailored management strategies, including cardioprotective medications or myocardial revascularization.
  • Integrating clinical evaluation, laboratory data, and non-invasive testing improves patient outcomes.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...